Free Radicals
Episodes
There are no longevity drugs today, but there will be soon - Dr. James Peyer, Cambrian Founder
28 Apr 2026
Contributed by Lukas
Dr. James Peyer is founder and CEO of Cambrian Bio. James has spent two decades working to bring the first longevity drug to market. In this time, he’...
Aging kills EVERYONE, but only because we're not trying hard enough - Longevity Activist Nathan Cheng
21 Apr 2026
Contributed by Lukas
Nathan Cheng is an activist who has dedicated his life and career to defeating aging and death. After going through an existential crisis and dropping...
The one-man biotech is only 10 years away - a16z-backed founder Kexin Huang
14 Apr 2026
Contributed by Lukas
Today’s guest is Kexin Huang. Kexin recently raised $13.5M from Andreessen Horowitz and Menlo Ventures in partnership with Anthropic, to build Phylo...
These 30-something Harvard Professors are making biology programmable - AbuGoot Lab
07 Apr 2026
Contributed by Lukas
Two young Harvard professors are coming for the supplements industry. Dr. Jonathan Gootenberg and Dr. Omar Abudayyeh run a joint lab at Harvard Medica...
Longevity politics with the Forbes 30U30 lobbyist changing DC - Dylan Livingston, A4LI
31 Mar 2026
Contributed by Lukas
Today’s guest is Dylan Livingston, the 28 year old founder of the Alliance for Longevity Initiatives, known as A4LI. With A4LI, Dylan has created Am...
Ex-BCG leader & David Sinclair’s COO on why evolution selected for aging, and how to get big pharma to invest into longevity therapies - Michael Ringel
24 Mar 2026
Contributed by Lukas
Dr. Michael Ringel is a leader in pharma and biotech who spent over 25 years at Boston Consulting Group, where he served as managing director and seni...
Longevity science & philosophy with the blogger leading theory at Sam Altman’s $1B+ startup - Jose, Author Nintil & Head of Theory at Retro
17 Mar 2026
Contributed by Lukas
Jose Luis Ricón Fernández de la Puente is the author of the popular blog Nintil, and Head of Theory at Retro Biosciences. Jose is a prolific blogger...
Inside the AI used by Sam Altman’s $1B+ longevity startup - Rico Meinl, Head of Applied AI at Retro Bio
10 Mar 2026
Contributed by Lukas
Retro Biosciences was seeded with $180M by OpenAI CEO Sam Altman to develop therapies to prevent and reverse age-related disease, and is widely recogn...
Why DNA Damage is Central to Aging — Christopher Bradley, CEO of Matter Bio
03 Mar 2026
Contributed by Lukas
Christopher is a serial entrepreneur who has dedicated himself to solving aging after his last startup Mana Health was acquired by NBC Universal. His ...
Why DNA Damage is Central to Aging — Chris Bradley, CEO of Matter Bio
03 Mar 2026
Contributed by Lukas
Christopher is a serial entrepreneur who has dedicated himself to solving aging after his last startup Mana Health was acquired by NBC Universal. His ...
The moral and economic case for delaying aging - Raiany Romanni
24 Feb 2026
Contributed by Lukas
Raiany Romanni-Klein is a Harvard and Brown-trained bioethicist focused on understanding why secular people like to narrate death and aging as good th...
Achieving Longevity Escape Velocity with patient avatars — Martin Borch Jensen, CSO of Gordian Biotechnology
17 Feb 2026
Contributed by Lukas
Martin Borch Jensen is a scientist, entrepreneur and longevity advocate. He is the co-founder and CSO of Gordian Biotechnology, a company whose platfo...
How a Stanford & Google AI pioneer invests in longevity biotech - Karl Pfleger
10 Feb 2026
Contributed by Lukas
Today’s guest is Karl Pfleger. After spending a decade as one of the first AI researchers at Google from 2002 to 2011, he has dedicated himself to t...
Finding genes at scale for age reversal - Shift Bio CEO Daniel Ives
03 Feb 2026
Contributed by Lukas
Dr. Daniel Ives is the founder of Shift Bioscience. Shift has built a novel single-cell aging clock that has enabled them to run high-throughput scree...
Polyphron CEO Matthew Osman on his Computation-First Tissue Foundry
27 Jan 2026
Contributed by Lukas
Polyphron is led by co-founder and CEO Matthew Osman, a twice-exited tech entrepreneur turned biotech founder. Matthew is building a computation-first...
NFX General Partner Dr. Omri Drory on how to end involuntary death
20 Jan 2026
Contributed by Lukas
Dr. Omri Amirav-Drory is a General Partner at NFX whose mission in life is to end involuntary death. Omri has backed companies like Mammoth Bioscience...
Jacob Kimmel - Pioneering a predictive biology revolution to reverse aging
13 Jan 2026
Contributed by Lukas
Dr. Jacob Kimmel is the President of NewLimit, a biotechnology company developing reprogramming medicines to treat age-related disease and extend huma...
How a serial tech entrepreneur is fomenting a revolution to cure aging and death - Adam Gries
16 Dec 2025
Contributed by Lukas
Adam Gries is a serial entrepreneur with four successful exits, and products that have reached over eighty million users. He has now set his sights on...
Reprogramming the cell from aged to healthy with siRNA - Dr. Janine & Rob (Junevity)
09 Dec 2025
Contributed by Lukas
Dr. Janine Sengstack and Rob Cahill, founders of the startup Junevity, are on a mission to extend lifespan and healthspan by combining AI and large sc...
Thiel fellow on how longevity can turn biotech around - Lada Nuzhna
02 Dec 2025
Contributed by Lukas
Lada Nuzhna is a researcher and founder driven by two questions: how did we get here, and how do we stay. Lada dropped out of college to pursue her bi...
How a Stanford aging biologist invests in longevity - Dr. Alex Colville
25 Nov 2025
Contributed by Lukas
Alex Colville, PhD, is a Co-founder and General Partner at Age1, one of the premier aging venture capital firms where he has invested in companies lik...
Celine Halioua - Making dogs live longer so humans can too
18 Nov 2025
Contributed by Lukas
Celine Halioua is the Founder & CEO of Loyal - the first company to ever receive FDA approval to develop a drug to extend lifespan in dogs, and th...